Clover Health, a healthcare company using data and technology to improve medical outcomes, recently announced expansion of its Medicare Advantage health plans in five new major markets for the plan year beginning Jan. 1, 2019.
According to company officials, Nashville and the other markets were selected based on a receptive customer base and the company's ability to delivery high quality Medicare Advantage plans by partnering with top local healthcare providers. Prior to the expansion, Clover served more than 30,000 seniors and those eligible for Medicare in parts of Georgia, New Jersey, Pennsylvania and Texas.
"Offering our plans in new cities and growing our presence in the markets we already serve is core to Clover's drive to improve the health of seniors across the country," said Clover Health CEO Vivek Garipalli. "Our approach of pairing cutting-edge technology with committed, personalized medical care is showing positive results for our members, and the expansion will allow Clover to reach even more Medicare beneficiaries."
Last month, Clover released results from the inaugural Clover Health Flu Shot Monitor, which revealed only 61 percent of Nashville seniors plan to get a flu shot this season. Nationally, 63 percent of the seniors surveyed said they planned to get the flu shot. "The flu is a deadly-serious issue and Nashville seniors are one of the most vulnerable populations during flu season," said Clover Health Chief Scientific Officer Kumar Dharmarajan, MD.
The most common reason cited in the survey for not wanting to get a flu shot was the concern that the shot would make individuals sick, followed by a belief that the flu shot wouldn't be effective. The findings open up lines of discussion for physicians to clear up myths and address concerns.
Officials said the survey illustrates the company's commitment to preventive healthcare and to leveraging data to proactively address potential illnesses on the front end. As part of this corporate tenet, Clover utilizes a proprietary technology platform, which has an 85 percent accuracy rate in identifying patients at risk of being admitted to the hospital in the next 28 days.